General form of registration statement for all companies including face-amount certificate companies

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.21.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:        
Net loss $ (4,082,000)      
Adjustments to reconcile net loss to net cash used in operating activities:        
Change in fair value of common stock warrant liability 2,646,000      
Changes in operating assets and liabilities        
Net cash used in operating activities (749,000)      
Evolv Technologies Holdings Inc [Member]        
Cash flows from operating activities:        
Net loss (13,755,000) $ (6,430,000) $ (27,392,000) $ (19,857,000)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization 452,000 172,000 1,065,000 535,000
Stock-based compensation 1,082,000 62,000 662,000 264,000
Noncash interest expense 2,344,000   25,000 498,000
Loss on extinguishment of debt     66,000 679,000
Provision recorded for allowance for doubtful accounts (63,000) (16,000) 47,000 16,000
Change in fair value of derivative liability 1,425,000      
Change in fair value of common stock warrant liability 736,000 0    
Changes in operating assets and liabilities        
Accounts receivable (874,000) (868,000) (464,000) (706,000)
Inventory (433,000) (621,000) (1,471,000) 229,000
Commission assets (391,000) (56,000) (1,785,000) (507,000)
Long-term contract assets (119,000)      
Prepaid expenses and other current assets (4,104,000) 52,000 (375,000) 1,259,000
Accounts payable 1,194,000 (300,000) 1,915,000 (144,000)
Deferred revenue (621,000) 24,000 2,341,000 1,372,000
Deferred rent (11,000) (8,000) (34,000) (26,000)
Accrued expenses and other current liabilities 1,100,000 (407,000) 2,160,000 1,155,000
Net cash used in operating activities (12,038,000) (8,396,000) (23,254,000) (15,178,000)
Cash flows from investing activities:        
Purchases of property and equipment (2,522,000) (271,000) (6,609,000) (731,000)
Net cash used in investing activities (2,522,000) (271,000) (6,609,000) (731,000)
Cash flows from financing activities:        
Proceeds from issuance of Series B-1 convertible preferred stock, net of issuance costs   2,994,000 2,994,000 22,366,000
Proceeds from exercise of stock options 455,000 67,000 442,000 28,000
Repayment of financing obligations (359,000) (75,000) (244,000) (120,000)
Proceeds from long-term debt, net of issuance costs 31,882,000 1,496,000 22,438,000 5,497,000
Repayment of principal on long-term debt     (8,404,000) (706,000)
Net cash provided by financing activities 31,978,000 4,482,000 17,226,000 27,788,000
Net increase (decrease) in cash and cash equivalents 17,418,000 (4,185,000) (12,637,000) 11,879,000
Cash and cash equivalents        
Cash and cash equivalents at beginning of period 4,704,000 17,341,000 17,341,000 5,462,000
Cash and cash equivalents at end of period 22,122,000 13,156,000 4,704,000 17,341,000
Supplemental disclosure of cash flow information        
Cash paid for interest 103,000 43,000 405,000 281,000
Cash paid for income taxes       2,000
Supplemental disclosure of non-cash activities        
Issuance of Series B1 convertible preferred stock for the conversion of convertible notes       6,595,000
Issuance of equity classified warrants $ 1,000 45,000 112,000 3,000
Transfers of inventory to property and equipment   $ 86,000 86,000 $ 1,879,000
Issuance of a nonrecourse promissory note with officer     $ 350,000